The 2-5A system in viral infection and apoptosis

Biomedicine and Pharmacotherapy

Volumn 52, Issue 9, 1998, Pages 386-390

  Castelli, J ^a   Wood, K A ^b   Youle, R J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TREVIGEN INC   (United States)

Author keywords

Apoptosis; Interferon; Ribonuclease

Indexed keywords

INTERFERON; ISOPROPYL THIOGALACTOSIDE; RIBONUCLEASE; RIBOSOME RNA; SYNTHETASE;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RNA DEGRADATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0032317403     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80006-7     Document Type: Article

References (47)

1. 1 Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980 ; 68 : 251-306
2. 2 Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev 1995 ; 5 : 105-11
3. 3 Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990 ; 348 ; 334-6
4. 4 Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993 ; 75 : 241-51
5. 5 Oltvai Z, Milliman C, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homologue, bax, that accelerates programmed cell death. Cell 1993 ; 74 : 609-19
6. 6 Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993 ; 361 : 365-9
7. 7 Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and bcl-2 proteins. Proc Natl Acad Sci USA 1992 ; 89 : 7742-6
8. 8 White E, Cipriani P, Sabbatini P, Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol 1991 ; 65 : 2968-78
9. 9 Tarodi B, Subramanian T, Chinnadura G. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 1994 ; 201 : 404-7
10. 10 Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993 ; 90 : 8479-83
11. 11 Gagliardini V, Fernandez P, Lee RK, Drexler HCA, Rotello RJ, Fishman MC, Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science 1994 ; 263 : 826-8
12. 12 Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991 ; 254 : 1388-90
13. 13 Duckett CS, Nava VE, Gedrich RW, Clem RJ, Dongen JLV, Gilfillan MC et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 1996 ; 15 : 2685-94
14. 14 White E, Sabbbatini P, Debbas M, Wold WSM, Kusher DI, Gooding LR. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor a. Mol Cell Biol 1992 ; 12 : 2570-80
15. 15 Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p 53. Cell 1990 ; 63 : 1129-36
16. 16 Lechner MS, Laimins LA. Inhibition of p 53 DNA binding by human papillomavirus E6 proteins. J Virol 1994 ; 68 : 4262-73
17. 17 Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992 ; 257 : 217-19
18. 18 Ackrill AM, Foster GR, Laxton CD, Flavell DM, Stark GR, Kerr IM. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res 1991 ; 19 : 4387-93
19. 19 Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens M. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991 ; 19 : 243-8
20. 20 Gutch MJ, Reich NC. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci USA 1991 ; 88 : 7913-17
21. 21 Kalvakolanu D, Bandyopadhyay S, Harter M, Sen G. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc Natl Acad Sci USA 1991 ; 88 : 7459-63
22. 22 Silverman RH, Cayley PJ, Knight M, Gilbert CS, Kerr IM. Control of the ppp(A2′p)nA system in HeLa cells: effects of interferon and virus infection. Eur J Biochem 1982 ; 124 : 131-8
23. 23 Nilsen TW, Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci USA 1979 ; 76 : 2600-4
24. 24 Gribaudo G, Lembo D, Cavallo G, Landolfo S, Lengyel P. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′ oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 1991 ; 65 : 1748-57
25. 25 Brown GE, Lebleu B, Kawakita M, Shaila S, Sen GC, Lengyel P. Increased endonuclease activity in an extract from mouse ehrlich seites tumor cells which had been treated with a partially purified interferon preparation: dependence on double-stranded RNA. Bioch Biophys Res Comm 1976 ; 69 : 114-22
26. 26 Sen GC, Lebleu B, Brown GE, Kawakita M, Slattery E, Lengyel P. Inteferon, double-stranded RNA and mRNA degradation. Nature 1976 ; 264 : 370-2
27. 27 Watling D, Serafinowska HT, Reese CB, Kerr IM. Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication. EMBO J 1985 ; 4 : 431-6
28. 28 Wreschner DH, James TC, Silverman RH, Kerr IM. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res 1981 ; 9 : 1571-81
29. 29 Aoki Y, Natori S. Activation of latent ribonuclease in the fat-body of fleshfly (sarcophaga peregrina) larvai on pupation. Biochem J 1981 ; 196 : 699-703
30. 30 Cidlowski JA. Glucocorticoids stimulate ribonucleic acid degradation in isolate rat thymic lymphocytes in vitro. Endocrinology 1982 ; 111 : 184-90
31. 31 Maor D. Concerning the mechanism of the increased RNAse activity in lymphatic cells following whole-body irradiation. Int J Rad Biol 1962 ; 6 : 93-103
32. 32 Perreault J, Lemieux R. Rapid apoptotic cell death of b-cell hybridomas in absence of gene expression. J Cell Phys 1993 ; 156 : 286-93
33. 33 Weymouth PP. The effect of a single systemic χ-irradiation of the C57BL mouse on the nucleodepolymerases of the thymus. Radiat Research 1958 ; 8 : 307-21
34. 34 Williams BRG, Golgher RR, Brown RE, Gilbert CS, Kerr IM. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 1979 ; 282 : 582-6
35. 35 Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC et al. A study of the interferon antiviral mechanism : apoptosis activation by the 2-5A system. J Exp Med 1997 ; 186 : 967-72
36. 36 Kerr IM, Brown RE, Clemens MJ, Gilbert CS. Interferon-mediated inhibition of cell-free-protein synthesis in response to double-stranded RNA. Eur J Biochem 1976 ; 69 : 551-61
37. 37 Houge G, Robaye B, Eikhom TS, Golstein J, Mellgren G, Gjertsen BT, Lanotte M, Døskeland SO. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol 1995 ; 15 : 2051-62
38. 38 Houge G, Døskeland SO, Bøe R, Lanotte M. Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett 1993 ; 315 : 16-20
39. 39 Delie J, Coppey-Moisan M, Magdelenat H. γ-Ray-induced transcription and apoptosis-associated loss of 28S rRNA in interphase human lymphocytes. Int J Radiat Biol 1993 ; 64 : 39-46
40. 40 Stark GR, Dower WJ, Schimke RT, Brown RE, Kerr IM. 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature 1979 ; 278 : 471-3
41. 41 Cohrs RJ, Goswami BB, Sharma OK. Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal. Biochemistry 1988 ; 27 : 3246-52
42. 42 Reid TR, Hersh CL, Kerr IM, Stark GR. Analysis of 2′,5′-oligoadenylates in cells and tissues. Anal Biochem 1984 ; 136 : 136-41
43. 43 Chapekar MS, Glazer RI. The synergistic cytocidal effect produced by immune interferon and tumor necrosis factor in HT-29 cells is associated with inhibition of rRNA processing and (2′,5′) oligo (A) activation of RNase L. Biochem Biophys Res Commun 1988 ; 151 : 1180-7
44. 44 Kitade Y, Alster D, Pabuccouglu A, Torrence PF. Uridine analogs of 2′,5′-oligoadenylates: On the biological role of the middle base of 2-5A trimer. Bioorg Chem 1991 ; 19 : 283-99
45. 45 Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci USA 1997 ; 94 : 3279-83
46. 46 Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 1993 ; 12 : 3297-304
47. 47 Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, Agol VI. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol 1995 ; 69 : 1181-9